Longboard Pharmaceuticals, Inc. (LBPH)
NASDAQ: LBPH · Real-Time Price · USD
59.77
-0.07 (-0.12%)
Nov 20, 2024, 4:00 PM EST - Market closed
Longboard Pharmaceuticals Market Cap
Longboard Pharmaceuticals has a market cap or net worth of $2.33 billion as of November 21, 2024. Its market cap has increased by 1,718.25% in one year.
Market Cap
2.33B
Enterprise Value
2.05B
1-Year Change
1,718.25%
Ranking
Category
Stock Price
$59.77
Market Cap Chart
Since the IPO on March 12, 2021, Longboard Pharmaceuticals's market cap has increased from $270.67M to $2.33B, an increase of 762.21%. That is a compound annual growth rate of 79.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 2.33B | 1,522.25% |
| Dec 29, 2023 | 143.86M | 156.33% |
| Dec 30, 2022 | 56.12M | -31.82% |
| Dec 31, 2021 | 82.31M | -69.59% |
| Mar 12, 2021 | 270.67M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Privia Health Group | 2.48B |
| Scholar Rock Holding | 2.48B |
| Twist Bioscience | 2.45B |
| iRhythm Technologies | 2.39B |
| Ardent Health Partners | 2.38B |
| Arrowhead Pharmaceuticals | 2.33B |
| LeMaitre Vascular | 2.30B |
| IDEAYA Biosciences | 2.27B |